CN102099042B - 用于贫血或幽门螺杆菌感染的单独(羟基吡喃酮铁)和组合(羟基吡喃酮铁和胃肠道炎症抑制剂)组合物 - Google Patents

用于贫血或幽门螺杆菌感染的单独(羟基吡喃酮铁)和组合(羟基吡喃酮铁和胃肠道炎症抑制剂)组合物 Download PDF

Info

Publication number
CN102099042B
CN102099042B CN200980125291.4A CN200980125291A CN102099042B CN 102099042 B CN102099042 B CN 102099042B CN 200980125291 A CN200980125291 A CN 200980125291A CN 102099042 B CN102099042 B CN 102099042B
Authority
CN
China
Prior art keywords
iron
application
compositions
acid
gastrointestinal tract
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN200980125291.4A
Other languages
English (en)
Chinese (zh)
Other versions
CN102099042A (zh
Inventor
迈克尔·亚瑟·施托克哈姆
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medical Research Council
Original Assignee
Iron Therapeutics Holdings AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Iron Therapeutics Holdings AG filed Critical Iron Therapeutics Holdings AG
Publication of CN102099042A publication Critical patent/CN102099042A/zh
Application granted granted Critical
Publication of CN102099042B publication Critical patent/CN102099042B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/191—Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CN200980125291.4A 2008-05-15 2009-05-14 用于贫血或幽门螺杆菌感染的单独(羟基吡喃酮铁)和组合(羟基吡喃酮铁和胃肠道炎症抑制剂)组合物 Active CN102099042B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0808835.3 2008-05-15
GBGB0808835.3A GB0808835D0 (en) 2008-05-15 2008-05-15 Therapeutic compositions
PCT/GB2009/001231 WO2009138761A1 (en) 2008-05-15 2009-05-14 Mono ( iron hydroxypyrone ) and combination ( iron hydroxypyrone and gi inflammation inhibiting agents ) compositions for anaemia or h. pylori infections

Publications (2)

Publication Number Publication Date
CN102099042A CN102099042A (zh) 2011-06-15
CN102099042B true CN102099042B (zh) 2014-08-13

Family

ID=39571409

Family Applications (1)

Application Number Title Priority Date Filing Date
CN200980125291.4A Active CN102099042B (zh) 2008-05-15 2009-05-14 用于贫血或幽门螺杆菌感染的单独(羟基吡喃酮铁)和组合(羟基吡喃酮铁和胃肠道炎症抑制剂)组合物

Country Status (9)

Country Link
US (2) US9248148B2 (cg-RX-API-DMAC7.html)
EP (1) EP2303289A1 (cg-RX-API-DMAC7.html)
JP (2) JP5769308B2 (cg-RX-API-DMAC7.html)
CN (1) CN102099042B (cg-RX-API-DMAC7.html)
AU (1) AU2009247762B2 (cg-RX-API-DMAC7.html)
CA (1) CA2724172C (cg-RX-API-DMAC7.html)
GB (1) GB0808835D0 (cg-RX-API-DMAC7.html)
SG (1) SG182137A1 (cg-RX-API-DMAC7.html)
WO (1) WO2009138761A1 (cg-RX-API-DMAC7.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104829272A (zh) 2009-12-22 2015-08-12 拉尔科营养品有限公司 有机螯合的矿物组合物及其制备方法
GB201101370D0 (en) 2011-01-27 2011-03-09 Iron Therapeutics Holdings Ag Process
CA3131334A1 (en) * 2012-07-05 2014-01-09 Ralco Nutrition, Inc. Agricultural compositions and applications utilizing mineral compounds
BR112016015766A2 (pt) 2014-01-06 2017-08-08 Iron Therapeutics Holdings Ag Regime de dosagem de trimaltol férrico
GB201404390D0 (en) * 2014-03-12 2014-04-23 Iron Therapeutics Holdings Ag Composition
RU2018121553A (ru) 2014-04-17 2019-03-06 Ралко Ньютришн, Инк. Сельскохозяйственные композиции и применения с использованием минеральных соединений
GB201418710D0 (en) 2014-10-21 2014-12-03 Iron Therapeutics Holdings Ag Dosage regimen
US11517540B2 (en) 2015-01-09 2022-12-06 The Board Of Trustees Of The University Of Illinois Restoring physiology in iron-deficient organisms using small molecules
JP2017032550A (ja) * 2015-07-30 2017-02-09 大塚製薬株式会社 胃粘膜萎縮の有無を判定する方法
AU2017242908B2 (en) * 2016-03-31 2022-11-17 Shield TX (UK) Limited Ferric maltol compositions for use in the treatment or prevention of cancer and tumours
GB2553099A (en) * 2016-08-19 2018-02-28 Shield Tx Uk Ltd Use
IT201700021676A1 (it) * 2017-02-28 2018-08-28 Carlo Angelo Ghisalberti Composizioni e sistemi di estrazione del ferro non-eme dalla dieta per uso nell’anemia sideropenica e carenze marziali

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998016218A1 (en) * 1996-10-11 1998-04-23 Pfylori Limited Use of metal complexes to treat gastrointestinal infections

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2128998B (en) * 1982-10-22 1986-07-16 Nat Res Dev Pharmaceutical compositions of iron complexes of 3 hydroxy-4-pyrone
US5177068A (en) 1984-04-19 1993-01-05 National Research Development Corporation Pharmaceutical compositions
EP0833627B1 (en) 1995-06-10 2004-08-18 Vitra Pharmaceuticals Ltd. Iron compounds, compositions, methods of making the same and uses thereof
GB9710699D0 (en) 1997-05-24 1997-07-16 Danbiosyst Uk Gastro-retentive controlled release system
GB0012487D0 (en) * 2000-05-24 2000-07-12 Pfylori Limited Use of metal compounds to treat gastrointestinal infections
CA2421410C (en) * 2000-09-19 2009-11-10 Vitra Pharmaceuticals Limited Iron compositions
GB0211500D0 (en) 2002-05-18 2002-06-26 Vitra Pharmaceuticals Ltd Method of forming iron hydroxypyrone compounds
EP1686982A4 (en) 2003-11-19 2007-03-21 Vecta Ltd METHODS AND COMPOSITIONS FOR THE TREATMENT OF DISEASES ASSOCIATED WITH HELICOBACTER PYLORI USING COMPOUNDS CONTAINING ENDOPEROXIDE BRIDGE
WO2007081744A2 (en) 2006-01-06 2007-07-19 Luitpold Pharmaceuticals, Inc. Methods and compositions for administration of iron
WO2007108712A1 (en) 2006-03-17 2007-09-27 Tatyana Vyacheslavovna Popkova Kit and method for treating or preventing anemia caused by iron deficiency
TW200843802A (en) * 2007-02-09 2008-11-16 Drugtech Corp Compositions for improving gastrointestinal nutrient and drug absorption

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998016218A1 (en) * 1996-10-11 1998-04-23 Pfylori Limited Use of metal complexes to treat gastrointestinal infections

Also Published As

Publication number Publication date
US9248148B2 (en) 2016-02-02
US20160120902A1 (en) 2016-05-05
CA2724172A1 (en) 2009-11-19
EP2303289A1 (en) 2011-04-06
JP2015083572A (ja) 2015-04-30
CN102099042A (zh) 2011-06-15
JP2011520855A (ja) 2011-07-21
SG182137A1 (en) 2012-07-30
AU2009247762B2 (en) 2014-08-14
WO2009138761A1 (en) 2009-11-19
US20110177172A1 (en) 2011-07-21
JP5769308B2 (ja) 2015-08-26
GB0808835D0 (en) 2008-06-18
AU2009247762A1 (en) 2009-11-19
CA2724172C (en) 2017-07-25

Similar Documents

Publication Publication Date Title
CA2724172C (en) Mono ( iron hydroxypyrone ) and combination ( iron hydroxypyrone and gi inflammation inhibiting agents ) compositions for anaemia or h. pylori infections
US20060134227A1 (en) Compositions including iron
US6197763B1 (en) Use of metal complexes to treat gastrointestinal infections
EP1318804B1 (en) Iron compositions
JP2004530659A (ja) 抗腫瘍および抗転移作用のための方法および処方
AU776732B2 (en) Pharmaceutical compositions containing copper, salicylic acid and vitamines C
US6426369B1 (en) Oxethazaine as antimicrobial agent
CN109310667B (zh) 用于治疗或预防癌症和肿瘤的麦芽酚铁组合物
HK1156552B (en) Mono (iron hydroxypyrone) and combination (iron hydroxypyrone and gi inflammation inhibiting agents) compositions for anaemia or h. pylori infections
HK1156552A (en) Mono (iron hydroxypyrone) and combination (iron hydroxypyrone and gi inflammation inhibiting agents) compositions for anaemia or h. pylori infections
Eddlestone Drug Therapies Used in Gastrointestinal
JP2000080031A (ja) 抗菌剤
HK40004283A (en) Ferric maltol compositions for use in the treatment or prevention of cancer and tumours

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1156552

Country of ref document: HK

C14 Grant of patent or utility model
GR01 Patent grant
REG Reference to a national code

Ref country code: HK

Ref legal event code: GR

Ref document number: 1156552

Country of ref document: HK

TR01 Transfer of patent right
TR01 Transfer of patent right

Effective date of registration: 20210416

Address after: Gateshead, UK

Patentee after: MEDICAL RESEARCH COUNCIL

Address before: Swiss Wollerau

Patentee before: IRON THERAPEUTICS HOLDINGS AG

EE01 Entry into force of recordation of patent licensing contract
EE01 Entry into force of recordation of patent licensing contract

Application publication date: 20110615

Assignee: JIANGSU AOSAIKANG PHARMACEUTICAL Co.,Ltd.

Assignor: MEDICAL RESEARCH COUNCIL

Contract record no.: X2022990000590

Denomination of invention: Single (iron hydroxypyrone) and combined (iron hydroxypyrone and gastrointestinal inflammation inhibitor) compositions for anemia or Helicobacter pylori infection

Granted publication date: 20140813

License type: Exclusive License

Record date: 20220901